In response to numerous inquiries from readers who could not believe that cannabidiol —CBD, a non-psychoactive, medically useful compound— was a Schedule 1 drug, supposedly dangerous and useless, O’Shaughnessy’s contacted the FDA and received this reply from Lisa Kubaska, PharmD, who works for the agency’s Center for Drug Evaluation and Research.


“CBD meets the definition of Schedule 1 under the Controlled Substance Act. The DEA is the regulatory agency.” 

Strangely believe it.